Yiming Peng is a director of nonclinical biostatistics at Genentech, A member of Roche Group. His group provides statistical support to process development and drug manufacturing. His areas of expertise include statistical process control, design of experiment, data analytics, machine learning, statistical consulting and collaboration. Prior to joining Genentech, he worked at Novartis and specialized in assay development and companion diagnostics. He graduated from Virginia Tech with PhD in Statistics.